QIX Dividenden Europa 36658003 / DE000SLA3LM9
16’064.05
Pkt
-40.81
Pkt
-0.25
%
10:08:40
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu QIX Dividenden Europa-Werten
| 13.02.25 | Siemens Buy | Deutsche Bank AG | |
| 13.02.25 | Siemens Buy | Jefferies & Company Inc. | |
| 13.02.25 | VINCI Buy | Jefferies & Company Inc. | |
| 12.02.25 | VINCI Buy | UBS AG | |
| 12.02.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 12.02.25 | VINCI Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.25 | Iberdrola Buy | UBS AG | |
| 11.02.25 | VINCI Outperform | RBC Capital Markets | |
| 10.02.25 | GSK Hold | Deutsche Bank AG | |
| 10.02.25 | VINCI Buy | Deutsche Bank AG | |
| 10.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Outperform | Bernstein Research | |
| 07.02.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | GSK Outperform | Bernstein Research | |
| 07.02.25 | VINCI Buy | Deutsche Bank AG | |
| 07.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 07.02.25 | VINCI Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Allianz Buy | Goldman Sachs Group Inc. | |
| 06.02.25 | VINCI Buy | UBS AG | |
| 06.02.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | VINCI Outperform | RBC Capital Markets | |
| 06.02.25 | Hannover Rück Buy | Jefferies & Company Inc. | |
| 06.02.25 | Hannover Rück Kaufen | DZ BANK | |
| 06.02.25 | TotalEnergies Outperform | RBC Capital Markets | |
| 06.02.25 | Hannover Rück Outperform | RBC Capital Markets | |
| 06.02.25 | GSK Hold | Deutsche Bank AG | |
| 06.02.25 | Hannover Rück Neutral | UBS AG | |
| 06.02.25 | Hannover Rück Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | TotalEnergies Buy | UBS AG | |
| 06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.02.25 | GSK Neutral | UBS AG | |
| 06.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | TotalEnergies Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | GSK Outperform | Bernstein Research | |
| 05.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | TotalEnergies Outperform | RBC Capital Markets | |
| 05.02.25 | Allianz Buy | Deutsche Bank AG | |
| 05.02.25 | TotalEnergies Buy | UBS AG |